Research & Development
Policy & Regulation
Trends & Finance
Mergers & Acquisitions: Page 3
Calibre Scientific acquires U.K. provider of scientific equipment, supplies, services
According to Calibre, SciQuip offers a broad and diversified portfolio whose product lines include centrifugation, incubation, ovens, freezers, freeze drying, liquid handling, and mission-critical laboratory equipment.
March 27, 2023
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Chembio “faces ongoing operational and financial challenges” if it remains an independent company, its CEO wrote in a letter to stockholders.
March 15, 2023
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Immucor's transfusion and transplant product lines complement Werfen's hemostasis, acute care, and autoimmunity business lines, and expand the parent firm's portfolio of specialized diagnostic products for hospitals and clinical laboratories.
March 15, 2023
PerkinElmer completes divestiture of Applied, Food, and Enterprise Services businesses to New Mountain Capital
The company said that its Life Sciences and Diagnostics business resulting from the divestiture will focus on developing and delivering novel scientific breakthroughs.
March 13, 2023
Calibre Scientific acquires AlphaScience to expand product portfolio, customer reach
AlphaScience will be integrated with Biozol Diagnostica, a subsidiary of Calibre Scientific, expanding its sales capabilities and product range for customers in the DACH region that comprises Germany, Austria, and Switzerland.
March 13, 2023
Fujifilm Healthcare Americas entering digital pathology, features newly branded solution at USCAP 2023
Fujifilm's solution delivers digital images for diagnosis 1.7 hours faster than glass slides, and facilitates instant sharing of patient cases with subspecialists, allowing for speedier diagnosis and treatment of patients, the firm said.
March 10, 2023
Oncocyte sells 70% stake in Razor Genomics to Dragon Scientific
The deal allows Razor Genomics to continue offering DetermaRx, a molecular stratification test to identify patients with IA-IIA non-squamous NSCLC who may be at low or high risk of having a recurrence.
February 22, 2023
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
The acquisition was agreed upon in July 2022 as an all-cash transaction valued at approximately $1.53 billion.
February 1, 2023
Matrix Medical Network sells laboratory service line to Karrington Clinical Laboratory
The transition of ownership is part of an overall strategy Matrix announced last year to refocus its portfolio of services on in-home health and care assessments.
January 4, 2023
Thermo Fisher Scientific, Heska complete previously announced acquisitions
Thermo Fisher completed its previously-announced acquisition of specialty diagnostics firm The Binding Site Group, while Heska closed the acquisition of point-of-care test developer LightDeck Diagnostics.
January 3, 2023
Fujifilm to enter digital pathology space with acquisition of Inspirata digital pathology platform
The acquisition signals Fujifilm's entry into the digital pathology market. At present, 85% of U.S., 86% of European, and 90% of Asian healthcare organizations are still running on analog pathology.
December 19, 2022
Integrated DNA Technologies acquires Invitae’s Archer NGS research assays for $48M
IDT said that the addition of next-generation sequencing research panels and bioinformatics expands IDT's position as an oncology research solutions provider.
December 20, 2022
Page 3 of 10